DK0888323T3 - Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler - Google Patents
Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midlerInfo
- Publication number
- DK0888323T3 DK0888323T3 DK97904019T DK97904019T DK0888323T3 DK 0888323 T3 DK0888323 T3 DK 0888323T3 DK 97904019 T DK97904019 T DK 97904019T DK 97904019 T DK97904019 T DK 97904019T DK 0888323 T3 DK0888323 T3 DK 0888323T3
- Authority
- DK
- Denmark
- Prior art keywords
- dihydrobenzofuran
- inflammatory agents
- compounds useful
- related compounds
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- HBEDSQVIWPRPAY-UHFFFAOYSA-N 2,3-dihydrobenzofuran Chemical compound C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 title 2
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/595,337 US5618835A (en) | 1996-02-01 | 1996-02-01 | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0888323T3 true DK0888323T3 (da) | 2004-08-09 |
Family
ID=24382842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97904019T DK0888323T3 (da) | 1996-02-01 | 1997-01-30 | Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler |
Country Status (15)
Country | Link |
---|---|
US (1) | US5618835A (da) |
EP (1) | EP0888323B1 (da) |
JP (1) | JP3095424B2 (da) |
KR (1) | KR100322402B1 (da) |
CN (1) | CN1125062C (da) |
AT (1) | ATE267187T1 (da) |
AU (1) | AU730262B2 (da) |
BR (1) | BR9707247A (da) |
CA (1) | CA2244203A1 (da) |
DE (1) | DE69729183T2 (da) |
DK (1) | DK0888323T3 (da) |
ES (1) | ES2221950T3 (da) |
MX (1) | MX9806250A (da) |
NO (1) | NO983530L (da) |
WO (1) | WO1997028147A1 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998039967A1 (en) * | 1997-03-12 | 1998-09-17 | The General Hospital Corporation | A method for treating or preventing alzheimer's disease |
CA2295055A1 (en) * | 1997-06-27 | 1999-01-07 | Kaneka Corporation | Heat shock factor activity inhibitor |
TR200001121T2 (tr) | 1997-10-24 | 2000-09-21 | Shionogi & Co., Ltd. | Antiromatizmal madde. |
US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
US6191154B1 (en) | 1998-11-27 | 2001-02-20 | Case Western Reserve University | Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases |
ES2315365T3 (es) | 2001-06-13 | 2009-04-01 | Magnachem International Laboratories, Inc. | Formulaciones de lactona y metodo de uso. |
US20030129186A1 (en) | 2001-07-25 | 2003-07-10 | Biomarin Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
CN1720242A (zh) | 2002-11-05 | 2006-01-11 | 马格纳化学国际实验室公司 | 合成的内酯制剂及其使用方法 |
SI1567112T1 (sl) * | 2002-11-22 | 2009-02-28 | Smithkline Beecham Corp | Thiazolidin-4-oni za inhibiranje proteinov hyak3 |
WO2005102315A1 (en) | 2004-04-23 | 2005-11-03 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations for pain control |
EP2671507A3 (en) | 2005-04-28 | 2014-02-19 | Proteus Digital Health, Inc. | Pharma-informatics system |
TW200716580A (en) * | 2005-06-08 | 2007-05-01 | Smithkline Beecham Corp | (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one |
KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료 |
US20100286041A1 (en) * | 2007-03-22 | 2010-11-11 | Smithkline Beecham Corporation | (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one |
CA2741526A1 (en) | 2008-10-24 | 2010-04-29 | Magnachem International Laboratories, Inc. | Method for screening for compounds selectively interacting with rad9 |
DE112010000714B4 (de) | 2009-01-27 | 2014-06-26 | National University Corporation Nagoya University | Membranspannungsmessvorrichtung |
PL3395372T3 (pl) | 2009-02-20 | 2022-07-25 | EnhanX Biopharm Inc. | Układ do dostarczania leków na bazie glutationu |
MX2011011833A (es) | 2009-05-06 | 2012-01-27 | Lab Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de partículas de fosfato de calcio-agente activo y métodos para utilizar las mismas. |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6019305B2 (ja) * | 1976-07-02 | 1985-05-15 | ウェルファイド株式会社 | ジヒドロベンゾフラン誘導体 |
IT1093805B (it) * | 1978-01-31 | 1985-07-26 | Erba Carlo Spa | Derivati del 2h-benzofuran-3-one e procedimento per la loro preparazione |
US4470440A (en) * | 1982-09-30 | 1984-09-11 | Thor Harry A | Impact producing tool |
DE3777366D1 (de) * | 1986-12-27 | 1992-04-16 | Takeda Chemical Industries Ltd | 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung. |
US4849428A (en) * | 1987-11-23 | 1989-07-18 | The Procter & Gamble Company | Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds, compositions and use |
JP2855341B2 (ja) * | 1988-06-10 | 1999-02-10 | 武田薬品工業株式会社 | 新規2―置換クマラン誘導体 |
US4966907A (en) * | 1988-08-12 | 1990-10-30 | Merck & Co., Inc. | 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis |
FR2645537B1 (fr) * | 1989-04-05 | 1994-03-04 | Fabre Medicament Pierre | Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique |
US4975457A (en) * | 1989-09-25 | 1990-12-04 | Merck & Co., Inc. | Trans 2,3-disubstituted-2,3-dihydro-5-hydroxy-benzofurans as inhibitors of leukotriene biosynthesis |
WO1991007396A1 (en) * | 1989-11-17 | 1991-05-30 | Meiji Milk Products Co., Ltd. | Benzofuran derivative, process for preparing the same, and pharmaceutical comprising the same as active ingredient |
US5091533A (en) * | 1990-03-12 | 1992-02-25 | Merck Frosst Canada, Inc. | 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
CA2078126A1 (en) * | 1990-03-27 | 1991-09-28 | Jerry Leroy Adams | 5-lipoxygenase inhibitors |
AU704085B2 (en) * | 1994-07-27 | 1999-04-15 | Vanderbilt University | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
US5684002A (en) * | 1994-09-07 | 1997-11-04 | The Procter & Gamble Company | Dihydorbenzofuran and related compounds useful as anti-inflammatory agents |
-
1996
- 1996-02-01 US US08/595,337 patent/US5618835A/en not_active Expired - Fee Related
-
1997
- 1997-01-30 WO PCT/US1997/001314 patent/WO1997028147A1/en active IP Right Grant
- 1997-01-30 AU AU18433/97A patent/AU730262B2/en not_active Ceased
- 1997-01-30 DE DE69729183T patent/DE69729183T2/de not_active Expired - Fee Related
- 1997-01-30 AT AT97904019T patent/ATE267187T1/de not_active IP Right Cessation
- 1997-01-30 EP EP97904019A patent/EP0888323B1/en not_active Expired - Lifetime
- 1997-01-30 JP JP09527762A patent/JP3095424B2/ja not_active Expired - Fee Related
- 1997-01-30 CN CN97192018A patent/CN1125062C/zh not_active Expired - Fee Related
- 1997-01-30 DK DK97904019T patent/DK0888323T3/da active
- 1997-01-30 BR BR9707247A patent/BR9707247A/pt not_active Application Discontinuation
- 1997-01-30 CA CA002244203A patent/CA2244203A1/en not_active Abandoned
- 1997-01-30 KR KR1019980705950A patent/KR100322402B1/ko not_active Expired - Fee Related
- 1997-01-30 ES ES97904019T patent/ES2221950T3/es not_active Expired - Lifetime
-
1998
- 1998-07-31 NO NO983530A patent/NO983530L/no not_active Application Discontinuation
- 1998-08-03 MX MX9806250A patent/MX9806250A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH11506121A (ja) | 1999-06-02 |
NO983530D0 (no) | 1998-07-31 |
EP0888323A1 (en) | 1999-01-07 |
BR9707247A (pt) | 1999-07-20 |
DE69729183T2 (de) | 2004-10-07 |
ES2221950T3 (es) | 2005-01-16 |
CA2244203A1 (en) | 1997-08-07 |
JP3095424B2 (ja) | 2000-10-03 |
AU1843397A (en) | 1997-08-22 |
US5618835A (en) | 1997-04-08 |
DE69729183D1 (de) | 2004-06-24 |
ATE267187T1 (de) | 2004-06-15 |
KR19990082222A (ko) | 1999-11-25 |
WO1997028147A1 (en) | 1997-08-07 |
AU730262B2 (en) | 2001-03-01 |
CN1210530A (zh) | 1999-03-10 |
KR100322402B1 (ko) | 2002-05-09 |
NO983530L (no) | 1998-09-30 |
MX9806250A (es) | 1998-11-30 |
EP0888323B1 (en) | 2004-05-19 |
CN1125062C (zh) | 2003-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0888323T3 (da) | Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler | |
EE04799B1 (et) | Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
FI973828A0 (fi) | Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi | |
FI962249A7 (fi) | Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten | |
DE122009000012I1 (de) | Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen. | |
BR9811099A (pt) | Inibidores de urocinase | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
BR9709062A (pt) | Composto, composição farmacêutica, e, uso de um composto. | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
DE69840603D1 (de) | Alpha-ketoamidhaltige multikatalytische protease inhibitoren | |
NO954878L (no) | Pyrrolderivater | |
DK0759687T3 (da) | Anvendelse af gelpræparater som bejdsemidler | |
DK1053000T3 (da) | Midler og fremgangsmåder til beskyttelse, behandling og udbedring af bindevæv | |
NO20012727L (no) | 3,4,5-trisubstituerte arylnitronforbindelser og farmasöytiske sammensetninger som inneholder samme | |
SE9801494D0 (sv) | Novel use | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
NO982229D0 (no) | Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
ID23373A (id) | Komposisi-komposisi farmasi yang mengandung turunan-turunan n-sulfonilindolin | |
BG100248A (bg) | Инхибитори на скваленсинтетаза | |
SE9504662D0 (sv) | New compounds | |
NO982562L (no) | Sammensetning for behandling av smerte | |
NO983526D0 (no) | Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler | |
ES2175661T3 (es) | Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
FI940150L (fi) | Koostumuksia sementtiä varten ja sementit, jotka on saatu näistä koostumuksista |